Drugs / Oseltamivir Phosphate Capsule
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02572583 Comparator | Nov 2014 → Nov 2016 | influenza | Dongfang Hospital Beijing University of Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oseltamivir Phosphate Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02572583 ↗ |
| Route | Oral | “Oseltamivir Phosphate Capsule, take orally” NCT02572583 ↗ |